Reuters logo
BRIEF-Cellnovo expects delay in 510(k) clearance of Cellnovo Diabetes Management System
September 8, 2017 / 5:37 AM / 13 days ago

BRIEF-Cellnovo expects delay in 510(k) clearance of Cellnovo Diabetes Management System

Sept 8 (Reuters) - CELLNOVO GROUP SA:

* PROVIDES UPDATE ON 510(K) SUBMISSION

* EXPECTS NEW STEP WILL EXTEND PREVIOUSLY EXPECTED TIMELINE FOR CLEARANCE OF DEVICE IN US AND WILL CONTINUE TO KEEP MARKET INFORMED OF PROGRESS

* 510(K) APPLICATION FOR CLEARANCE OF THE CELLNOVO DIABETES MANAGEMENT SYSTEM‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below